![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 409/10 | |
A61K 31/381 | |||
A61P 3/10 |
(11) | Patento numeris | 3298007 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16730933.5 |
Europos patento paraiškos padavimo data | 2016-05-18 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-03-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-22 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/033071 |
Data | 2016-05-18 |
(87) | Numeris | WO 2016/191173 |
Data | 2016-12-01 |
(30) | Numeris | Data | Šalis |
201562165265 P | 2015-05-22 | US |
(72) |
BRESLIN, David T., US
FAWZY, Nagy E., US
SCHAEFER, John, US
|
(73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
(54) | ANHYDROUS CRYSTALLINE FORM OF (1S)-1,5-ANHYDRO-1-[3-[[5-(4-FLUOROPHENYL)-2-THIENYL]METHYL]-4-METHYLPHENYL]-D-GLUCITOL |
ANHYDROUS CRYSTALLINE FORM OF (1S)-1,5-ANHYDRO-1-[3-[[5-(4-FLUOROPHENYL)-2-THIENYL]METHYL]-4-METHYLPHENYL]-D-GLUCITOL |